Phase II study of novel orally PI3Kα/δ inhibitor TQ-B3525 in relapsed and/or refractory follicular lymphoma
Article in Signal Transduction and Targeted Therapy (April 2024)
The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.
Article in Signal Transduction and Targeted Therapy (April 2024)
Article in Oncology Letters (March 2024)
Article in Chinese Journal of Hematology (December 2023)